---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-006220"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:20:12.454976+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Zomedica Q1 revenue up 45% to $5.5M; net loss widens to $6.4M

## Summary
- Revenue $5.5M (+45% YoY); gross margin 70%; net loss $6.4M ($0.007/share) vs $3.9M loss a year ago.
- Diagnostic segment revenue $0.4M (+300% YoY); Therapeutic segment $5.1M (+38% YoY).
- Cash and securities $147.5M; cash used in Q1 was $8.3M including $4.0M TRUFORMA licensing fees.
- Paid $250k non-refundable deposit to exercise acquisition option for Structured Monitoring Products (VetGuardian).
- Amended Georgia lease to add 6,000 sq ft for TRUFORMA cartridge manufacturing; TRUVIEW digital microscopy system launch planned in Q2.

## SEC filing metadata
- accession: 0001654954-23-006220
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/0001654954-23-006220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-006220
- JSON: https://secwatch.observer/filing/0001654954-23-006220.json
- Plain text: https://secwatch.observer/filing/0001654954-23-006220.txt

## Key facts
- Earnings Releases
  Zomedica Corp. reported three months ended March 31, 2023 results: revenue $5.5 million.
  - Period: three months ended March 31, 2023
  - Revenue: $5.5 million
  - Result: reported results
  source text: Revenue for the first quarter of 2023 was $5.5 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495423006220/0001654954-23-006220-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.